Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Kim W Hansen"'
Autor:
Signe Højstrup, Kim W. Hansen, Ulrik Talleruphuus, Lisbeth Marner, Søren Galatius, Maira Rauf, Louise H. Bjerking, Lars Jakobsen, Evald H. Christiansen, Kirsten Bouchelouche, Hanne Christensen, Eva I. B. Prescott
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 12, Iss 12 (2023)
Background Coronary microvascular disease (CMD) may be part of a systemic small vessel disease that also manifests as neurological impairment and kidney disease. However, clinical evidence supporting a potential link is scarce. We assessed whether CM
Externí odkaz:
https://doaj.org/article/c38d8d7873cb4e03a24cf2b7016130bf
Autor:
Maira Rauf, Kim W Hansen, Søren Galatius, Niels Wiinberg, Louise Scouborg Brinth, Signe Højstrup, Ulrik Talleruphuus, Eva Prescott
Publikováno v:
European heart journal. Cardiovascular Imaging.
Aims Myocardial perfusion imaging with 82-rubidium positron emission tomography (82Rb-PET) is increasingly used to assess stable coronary artery disease (CAD). We aimed to evaluate the prognostic value of 82Rb-PET-derived parameters in patients with
Autor:
Kim W Hansen, Rikke Sørensen, Raban Jeger, Christoph Kaiser, Matthias Pfisterer, Søren Galatius
Publikováno v:
Circulation. 132
Introduction: The new generation thinner-strut silicon carbide (SiC) coated cobalt chromium (CoCr) bare-metal stents (BMS) are designed to accelerate rapid endothelialisation and reduce thrombogenicity when implanted in coronary arteries. However, sm
Autor:
Louise H Bjerking, Kim W Hansen, Rikke Sørensen, Raban Jeger, Christoph Kaiser, Matthias Pfisterer, Søren Galatius
Publikováno v:
Circulation. 132
Objectives: Drug-eluting stents (DES) are associated with lower rates of target vessel revascularization (TVR) compared with bare-metal stents (BMS), possibly with a particular benefit in women. Inferences on efficacy and safety of DES compared to BM